Current Challenges in the Development of Platelet‐Rich Plasma‐Based Therapies
BioMed Research International · 2024-01 · 2024 (1)
DOI: 10.1155/2024/6444120 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift BioMed Research International, online erschienen am 09.08.2024. Verfasst von Jon Mercader-Ruiz und 9 weiteren Autor:innen. Beteiligte Einrichtung: Microfluidics Cluster UPV/EHU BIOMICs Microfluidics Group Lascaray Research Center University of the Basque Country UPV/EHU 01006, Vitoria-Gasteiz, S…. Hauptthemen laut MEDLINE: Platelet-Rich Plasma. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Economía y Competitividad, European Regional Development Fund.
Abstract (Originalsprache)
Nowadays, biological therapies are booming and more of these formulations are coming to the market. Platelet‐rich plasma, or PRP, is one of the most widely used biological therapies due to its ease of obtention and autologous character. Most of the techniques to obtain PRP are focusing on new processes and methods of optimization. However, not enough consideration is being given to modify the molecular components of PRP to generate more effective formulations with the aim of improving PRP treatments. Therefore, this review covers different novel PRP‐obtaining methods that attempt to modify the molecular composition of the plasma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Microfluidics Cluster UPV/EHU BIOMICs Microfluidics Group Lascaray Research Center University of the Basque Country UPV/EHU 01006, Vitoria-Gasteiz, Spain.
- Advance Biological Therapy Unit Hospital Vithas Vitoria 01008, Vitoria-Gasteiz, Spain.
- Arthroscopic Surgery Unit Hospital Vithas Vitoria 01008, Vitoria-Gasteiz, Spain.
- Microfluidics Cluster UPV/EHU Analytical Microsystems & Materials for Lab-on-a-Chip (AMMa-LOAC) Group Analytical Chemistry Department University of the Basque Country UPV/EHU 48940, Leioa, Spain.
- Basque Foundation of Science IKERBASQUE 48009, Bilbao, Spain.
ORCID-Profile: Maider Beitia, Diego Delgado, Fernando Benito-Lopez, Lourdes Basabe-Desmonts, Mikel Sánchez
Förderung
- Ministerio de Economía y Competitividad
- European Regional Development Fund
Zitieren
APA
Mercader-Ruiz, J., Beitia, M., Delgado, D., Sánchez, P., Porras, B., Gimeno, I., González, S., Benito-Lopez, F., Basabe-Desmonts, L., & Sánchez, M. (2024). Current Challenges in the Development of Platelet‐Rich Plasma‐Based Therapies. BioMed Research International, 2024(1). https://doi.org/10.1155/2024/6444120
Vancouver
Mercader-Ruiz J, Beitia M, Delgado D, Sánchez P, Porras B, Gimeno I, et al. Current Challenges in the Development of Platelet‐Rich Plasma‐Based Therapies. BioMed Research International. 2024;2024(1). doi:10.1155/2024/6444120
BibTeX
@article{MercaderRuiz2024,
author = {Mercader-Ruiz, Jon and Beitia, Maider and Delgado, Diego and Sánchez, Pello and Porras, Begoña and Gimeno, Irene and González, Sergio and Benito-Lopez, Fernando and Basabe-Desmonts, Lourdes and Sánchez, Mikel},
title = {Current Challenges in the Development of Platelet‐Rich Plasma‐Based Therapies},
journal = {BioMed Research International},
year = {2024},
volume = {2024},
number = {1},
doi = {10.1155/2024/6444120}
}
EUVIMED